| __timestamp | BioMarin Pharmaceutical Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 621276000 | 11947000000 |
| Thursday, January 1, 2015 | 737887000 | 12651000000 |
| Friday, January 1, 2016 | 907234000 | 14481000000 |
| Sunday, January 1, 2017 | 1071860000 | 14710000000 |
| Monday, January 1, 2018 | 1175948000 | 16014000000 |
| Tuesday, January 1, 2019 | 1344582000 | 18067000000 |
| Wednesday, January 1, 2020 | 1336183000 | 30745000000 |
| Friday, January 1, 2021 | 1375760000 | 36445000000 |
| Saturday, January 1, 2022 | 1612370000 | 36022000000 |
| Sunday, January 1, 2023 | 1842161000 | 34313000000 |
| Monday, January 1, 2024 | 48300000000 |
Data in motion
In the competitive landscape of pharmaceuticals, understanding who leads in profitability is crucial. Over the past decade, Bristol-Myers Squibb Company has consistently outperformed BioMarin Pharmaceutical Inc. in terms of gross profit. From 2014 to 2023, Bristol-Myers Squibb's gross profit surged by nearly 187%, peaking at approximately $36 billion in 2021. In contrast, BioMarin's growth, while steady, was more modest, with a 196% increase, reaching around $1.8 billion in 2023.
This stark difference highlights Bristol-Myers Squibb's dominant market position and strategic prowess. Despite BioMarin's impressive growth rate, its absolute figures remain dwarfed by its larger competitor. This data not only underscores the financial health of these companies but also reflects broader industry trends where scale and innovation drive profitability. As the pharmaceutical sector evolves, these insights offer a glimpse into the future dynamics of market leadership.
Eli Lilly and Company and Bristol-Myers Squibb Company: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Bristol-Myers Squibb Company and MorphoSys AG
Gross Profit Comparison: Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated Trends
Who Generates Higher Gross Profit? Gilead Sciences, Inc. or BioMarin Pharmaceutical Inc.
Gross Profit Comparison: Alnylam Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc. Trends
Genmab A/S and BioMarin Pharmaceutical Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Incyte Corporation and BioMarin Pharmaceutical Inc. Trends
BioMarin Pharmaceutical Inc. and Catalent, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? BioMarin Pharmaceutical Inc. or Jazz Pharmaceuticals plc
Gross Profit Trends Compared: BioMarin Pharmaceutical Inc. vs Amneal Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing BioMarin Pharmaceutical Inc. and Bausch Health Companies Inc.
BioMarin Pharmaceutical Inc. and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis